Working against our endogenous circadian clock: Breast cancer and electric lighting in the modern world.

[1]  Yong Zhu,et al.  Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis. , 2009, Cancer letters.

[2]  R. Stevens.  Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. , 2009, International journal of epidemiology.

[3]  R. Stevens.  Electric light causes cancer? Surely you're joking, Mr. Stevens. , 2009, Mutation research.

[4]  J. Burch,et al.  Shiftwork impacts and adaptation among health care workers. , 2009, Occupational medicine.

[5]  T. Holford,et al.  Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. , 2009, Cancer research.

[6]  S. Archer,et al.  Association between Specific Diurnal Preference Questionnaire Items and PER3 VNTR Genotype , 2009, Chronobiology international.

[7]  S. Golden,et al.  How a cyanobacterium tells time. , 2008, Current opinion in microbiology.

[8]  David Sliney,et al.  Sensitivity of the Human Circadian System to Short-Wavelength (420-nm) Light , 2008, Journal of biological rhythms.

[9]  Erin L. McDearmon,et al.  The genetics of mammalian circadian order and disorder: implications for physiology and disease , 2008, Nature Reviews Genetics.

[10]  Kai-Florian Storch,et al.  Physiological significance of a peripheral tissue circadian clock , 2008, Proceedings of the National Academy of Sciences.

[11]  Y. Ba,et al.  The Circadian Gene NPAS2, a Putative Tumor Suppressor, Is Involved in DNA Damage Response , 2008, Molecular Cancer Research.

[12]  H. Kolstad.  Nightshift work and risk of breast cancer and other cancers--a critical review of the epidemiologic evidence. , 2008, Scandinavian journal of work, environment & health.

[13]  T. Holford,et al.  Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk , 2008, Breast Cancer Research and Treatment.

[14]  Kurt Straif,et al.  Carcinogenicity of shift-work, painting, and fire-fighting. , 2007, The Lancet. Oncology.

[15]  K. Yu,et al.  Variants in circadian genes and prostate cancer risk: a population-based study in China , 2007, Prostate Cancer and Prostatic Diseases.

[16]  J. O’Neill,et al.  Insight into the circadian clock within rat colonic epithelial cells. , 2007, Gastroenterology.

[17]  Mark S. Rea,et al.  Meeting Report: The Role of Environmental Lighting and Circadian Disruption in Cancer and Other Diseases , 2007, Environmental health perspectives.

[18]  Paolo Sassone-Corsi,et al.  Circadian Clock and Breast Cancer: A Molecular Link , 2007, Cell cycle.

[19]  D. Dijk,et al.  PER3 Polymorphism Predicts Sleep Structure and Waking Performance , 2007, Current Biology.

[20]  P. Boyle,et al.  Ala394Thr polymorphism in the clock gene NPAS2: A circadian modifier for the risk of non‐Hodgkin's lymphoma , 2007, International journal of cancer.

[21]  Michael Smolensky,et al.  Biological Clocks and Shift Work: Circadian Dysregulation and Potential Long-term Effects , 2006, Cancer Causes & Control.

[22]  Peter Boyle,et al.  Does “Clock” Matter in Prostate Cancer? , 2006, Cancer Epidemiology Biomarkers & Prevention.

[23]  D. Earnest,et al.  Circadian clock and cell cycle gene expression in mouse mammary epithelial cells and in the developing mouse mammary gland , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  M. Dubocovich,et al.  Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. , 2005, Cancer research.

[25]  W. Johnson,et al.  Melatonin, Sleep, and Shift Work Adaptation , 2005, Journal of occupational and environmental medicine.

[26]  Ming-Feng Hou,et al.  Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. , 2005, Carcinogenesis.

[27]  A. Papanikolaou,et al.  Cyclin D1 in breast cancer pathogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Richard G. Stevens,et al.  Circadian Disruption and Breast Cancer: From Melatonin to Clock Genes , 2005, Epidemiology.

[29]  Tongzhang Zheng,et al.  Period3 structural variation: a circadian biomarker associated with breast cancer in young women. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  I. Weaver,et al.  Epigenetic programming by maternal behavior , 2004, Nature Neuroscience.

[31]  R. Stevens,et al.  In utero alcohol exposure increases mammary tumorigenesis in rats , 2004, British Journal of Cancer.

[32]  S. Yamaguchi,et al.  Control Mechanism of the Circadian Clock for Timing of Cell Division in Vivo , 2003, Science.

[33]  Josephine Arendt,et al.  A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. , 2003, Sleep.

[34]  L. Fu,et al.  The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.

[35]  Eviatar Nevo,et al.  Origin and evolution of circadian clock genes in prokaryotes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Kai-Florian Storch,et al.  Extensive and divergent circadian gene expression in liver and heart , 2002, Nature.

[37]  Mark S. Rea,et al.  Light in the Built Environment: Potential role of Circadian Disruption in Endocrine Disruption and Breast Cancer , 2001, Cancer Causes & Control.

[38]  R. Kronauer,et al.  Stability, precision, and near-24-hour period of the human circadian pacemaker. , 1999, Science.

[39]  D. Trichopoulos.  Hypothesis: does breast cancer originate in utero? , 1990, The Lancet.

[40]  R. Stevens,et al.  Electric power use and breast cancer: a hypothesis. , 1987, American journal of epidemiology.